This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock LOGC vs. MYTE, BWMX, VGII, OG, WNW, OGBLY, BJRI, ETD, BBW, and BHShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include MYT Netherlands Parent B.V. (MYTE), Betterware de México, S.A.P.I. de C.V. (BWMX), Virgin Group Acquisition Corp. II (VGII), Onion Global (OG), Meiwu Technology (WNW), Onion Global (OGBLY), BJ's Restaurants (BJRI), Ethan Allen Interiors (ETD), Build-A-Bear Workshop (BBW), and Biglari (BH). LogicBio Therapeutics vs. Its Competitors MYT Netherlands Parent B.V. Betterware de México, S.A.P.I. de C.V. Virgin Group Acquisition Corp. II Onion Global Meiwu Technology Onion Global BJ's Restaurants Ethan Allen Interiors Build-A-Bear Workshop Biglari MYT Netherlands Parent B.V. (NYSE:MYTE) and LogicBio Therapeutics (NASDAQ:LOGC) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability. Is MYTE or LOGC more profitable? MYT Netherlands Parent B.V. has a net margin of -3.98% compared to LogicBio Therapeutics' net margin of -141.03%. MYT Netherlands Parent B.V.'s return on equity of -5.88% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MYT Netherlands Parent B.V.-3.98% -5.88% -3.63% LogicBio Therapeutics -141.03%-81.98%-52.13% Does the media favor MYTE or LOGC? In the previous week, MYT Netherlands Parent B.V. had 1 more articles in the media than LogicBio Therapeutics. MarketBeat recorded 1 mentions for MYT Netherlands Parent B.V. and 0 mentions for LogicBio Therapeutics. MYT Netherlands Parent B.V.'s average media sentiment score of 1.75 beat LogicBio Therapeutics' score of 0.00 indicating that MYT Netherlands Parent B.V. is being referred to more favorably in the media. Company Overall Sentiment MYT Netherlands Parent B.V. Very Positive LogicBio Therapeutics Neutral Do insiders & institutionals have more ownership in MYTE or LOGC? 10.1% of MYT Netherlands Parent B.V. shares are held by institutional investors. Comparatively, 46.1% of LogicBio Therapeutics shares are held by institutional investors. 1.9% of MYT Netherlands Parent B.V. shares are held by company insiders. Comparatively, 8.1% of LogicBio Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, MYTE or LOGC? MYT Netherlands Parent B.V. has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, LogicBio Therapeutics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Do analysts prefer MYTE or LOGC? MYT Netherlands Parent B.V. currently has a consensus price target of $14.00, suggesting a potential upside of 61.85%. Given MYT Netherlands Parent B.V.'s stronger consensus rating and higher probable upside, equities analysts plainly believe MYT Netherlands Parent B.V. is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MYT Netherlands Parent B.V. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, MYTE or LOGC? MYT Netherlands Parent B.V. has higher revenue and earnings than LogicBio Therapeutics. MYT Netherlands Parent B.V. is trading at a lower price-to-earnings ratio than LogicBio Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMYT Netherlands Parent B.V.$881.44M0.84-$26.95M-$0.43-20.12LogicBio Therapeutics$287M0.67-$317M-$5.79-1.27 SummaryMYT Netherlands Parent B.V. beats LogicBio Therapeutics on 12 of the 16 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LOGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$193.16M$330.17M$26.96B$9.76BDividend YieldN/A7.71%172.55%4.03%P/E Ratio-1.273.1627.2826.44Price / Sales0.6711.798.33154.88Price / CashN/A58.4757.7959.42Price / Book0.823.814.686.59Net Income-$317M$4.74M$872.89M$265.92M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics1.2251 of 5 stars$7.35-1.7%N/A+37.8%$193.16M$287M-1.2762MYTEMYT Netherlands Parent B.V.2.044 of 5 stars$8.44+3.9%$14.00+65.9%+140.5%$723.30M$881.44M-19.631,240News CoveragePositive NewsBWMXBetterware de México, S.A.P.I. de C.V.3.2776 of 5 stars$13.35-0.3%N/A-2.6%$499.68M$14.17B9.531,270News CoverageVGIIVirgin Group Acquisition Corp. IIN/A$1.49+2.8%N/A+18.3%$74.97MN/A0.00N/AOGOnion GlobalN/AN/AN/AN/A$25.02M$2.04B0.00796WNWMeiwu TechnologyN/A$1.78+0.7%N/A-88.8%$5.65M$158.49K0.0050OGBLYOnion GlobalN/AN/AN/AN/A$11KN/A0.00860BJRIBJ's Restaurants3.9106 of 5 stars$33.65-4.1%$39.67+17.9%+5.4%$776.34M$1.36B28.2821,000Positive NewsETDEthan Allen Interiors3.4388 of 5 stars$30.16+0.4%$30.00-0.5%-6.6%$763.66M$614.65M15.013,404Positive NewsGap UpBBWBuild-A-Bear Workshop2.3196 of 5 stars$55.95-1.1%$52.67-5.9%+141.6%$747.47M$496.40M13.455,100Trending NewsEarnings ReportAnalyst ForecastBHBiglari2.151 of 5 stars$303.23-0.8%N/A+78.8%$691.48M$377.18M2.072,535News Coverage Related Companies and Tools Related Companies MYT Netherlands Parent B.V. Alternatives Betterware de México, S.A.P.I. de C.V. Alternatives Virgin Group Acquisition Corp. II Alternatives Onion Global Alternatives Meiwu Technology Alternatives Onion Global Alternatives BJ's Restaurants Alternatives Ethan Allen Interiors Alternatives Build-A-Bear Workshop Alternatives Biglari Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOGC) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access